Pfizer (NYSE: PFE) has had to stop another cancer drug during a late stage in the process. This time the company halted testing on therapy Sutent has failed due to a high rate of serious problems in patients with liver cancer after taking doses of the medication. The announcement of the failure is happening at […]
Pfizer (NYSE: PFE) Stops Cancer Drug Testing, Remains Confident in Sutent was created by and is property of American Consumer News.
